Abstract
This study investigated the characteristics and mechanisms of eravacycline resistance and heteroresistance in clinical Klebsiella pneumoniae isolates. A total of 393 clinical K. pneumoniae isolates were collected and subjected to eravacycline and tigecycline MIC determinations using the agar dilution method. Eravacycline heteroresistance was assessed by a population analysis profile (PAP). The expression levels of efflux pumps and their regulators were determined by quantitative reverse-transcription PCR (qRT-PCR). This study identified 67 eravacycline-nonsusceptible isolates; among the extended-spectrum β-lactamase (ESBL)-positive isolates, eravacycline-nonsusceptible isolates were detected more frequently than tigecycline-nonsusceptible isolates (21.7% vs. 9.4%, p = 0.001). The study sample was observed to include 20 K. pneumoniae isolates with eravacycline heteroresistance. Compared to the reference strain, oqxA or oqxB overexpression was observed in nine eravacycline-nonsusceptible isolates (range, 35.64–309.02-fold) and 13 eravacycline-heteroresistant isolates (8.42–296.34-fold). The overexpression of macA or macB was detected in 12 eravacycline-heteroresistant isolates (3.23–28.35-fold). Overexpression of the efflux pump regulator gene ramA was observed in 11 eravacycline-nonsusceptible isolates (3.33–94.05-fold) and 18 eravacycline-heteroresistant isolates (3.89–571.70-fold). The eravacycline MICs were increased by one–fourfold by overexpression of oqxAB or macAB in three eravacycline-sensitive isolates. In conclusion, the overexpression of OqxAB and MacAB efflux pumps and the transcriptional regulator RamA were suggested to be involved in K. pneumoniae eravacycline resistance and heteroresistance.
Highlights
Introduction Concerns regarding theGram-negative pathogen Klebsiella pneumoniae, a member of the EnterobacteriaceaeEnterobacteriaceae are an emergent global health threat because carbapenems had previously been effective for eliminating multidrug-resistant Gram-negative bacterial infections[2]
Tigecycline and eravacycline susceptibilities among clinical K. pneumoniae isolates
Among the ESBL-positive isolates, eravacycline nonsusceptibility was more common than tigecycline nonsusceptibility (21.7% vs. 9.4%, P = 0.001)
Summary
Gram-negative pathogen Klebsiella pneumoniae, a member of the Enterobacteriaceae. Enterobacteriaceae are an emergent global health threat because carbapenems had previously been effective for eliminating multidrug-resistant Gram-negative bacterial infections[2]. Increases in carbapenemresistant K. pneumoniae (CR-Kp) frequencies worldwide are resulting in K. pneumoniae infections that are very difficult to treat and are associated with higher mortality rates[3]. Zheng et al Emerging Microbes & Infections (2018)7:139 Characteristic. ESBLa Positive (n = 203) Negative (n = 145). CR-Kp Positive (n = 45) Negative (n = 348) Total (n = 393)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
